Candida auris emergence in the Himalayan foothills: First case report from Uttarakhand, India

Document Type : Case report

Authors

Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, India

Abstract

Background and Purpose: Candida auris is a rapidly emerging fungus, which is considered globally a cause of concern for public health. This report describes the first case of C. auris fungemia from a tertiary care hospital in the hilly state of Uttarakhand in India. Case report: The patient was a 37-year-old female who underwent a Whipple procedure for the carcinoma of the head of the pancreas. She developed fever 12 days after the operation while recovering from surgery in the hospital. Blood culture yielded C. auris which was identified by the matrix-assisted laser desorption/ionization-time of flight mass spectrometry (Bruker Daltonics, Germany). The patient was successfully treated with caspofungin. Conclusion: In conclusion, C. auris is potentially multidrug resistant, resulting in nosocomial outbreaks and sporadic infections which can be potentially prevented when identified early by implementing contact precautionsBackground and Purpose: Candida auris is a rapidly emerging fungus, which is considered globally a cause of concern for public health. This report describes the first case of C. auris fungemia from a tertiary care hospital in the hilly state of Uttarakhand in India.
Case report: The patient was a 37-year-old female who underwent a Whipple procedure for the carcinoma of the head of the pancreas. She developed fever 12 days after the operation while recovering from surgery in the hospital. Blood culture yielded C. auris which was identified by the matrix-assisted laser desorption/ionization-time of flight mass spectrometry (Bruker Daltonics, Germany). The patient was successfully treated with caspofungin.
Conclusion: In conclusion, C. auris is potentially multidrug resistant, resulting in nosocomial outbreaks and sporadic infections which can be potentially prevented when identified early by implementing contact precautions.

Keywords

References

1. Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Taghizadeh Armaki M, RoodgariS, et al. Candida auris otomycosis in Iran and review of recent literature. Mycoses. 2019; 62(2):101-5.
2. Vogelzang EH, Weersink AJ, van Mansfeld R, Chow NA, Meis JF, van Dijk K. The first two cases of Candida auris in the Netherlands. J Fungi (Basel). 2019; 5(4):E91. 
3. Tracking Candida auris. Centres for Disease Control and Prevention. Available at: URL: https://www.cdc.gov/fungal/ candida-auris/tracking-c-auris.html; 2019.
4. Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: new kid on the block in hospital associated infections? J Hosp Infect. 2016; 94(3):209‐12. 
5. Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015; 41(2):285-95.
6. Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017; 72(6):1794-801.
7. White TJ, Bruns TD, Lee SB, Taylor JW, Innis N, Gelfand D, et al. PCR-protocols and applications-a laboratory manual. New York: Academic Press; 1990. P. 315-22.
8. Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019; 25(9):1780-81. 
9. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017; 64(2):134-40.
Current Medical Mycology
Volume 6, Issue 1
March 2020
Pages 47-50

Files

History

  • Receive Date: 14 June 2019
  • Accept Date: 29 December 2019
  • First Publish Date: 01 March 2020

Share

How to cite

Statistics